Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.
Access Report Details at: https://www.themarketreports.com/report/global-intravenoiv-iron-drugs-market-research-report
The global Intraveno(IV) Iron Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intraveno(IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intraveno(IV) Iron Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Key companies profiled in Intraveno(IV) Iron Drugs Market report are Allergan, Amag Pharmaceuticals, Galenica, Actavis, American Regent,Sanofi, Luitpold Pharmaceuticals,Fresenius Medical Care, Pharmacosmos and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.
Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1403201
Table of Content
1 Intraveno(IV) Iron Drugs Market Overview
2 Global Intraveno(IV) Iron Drugs Market Competition by Manufacturers
3 Global Intraveno(IV) Iron Drugs Production Market Share by Regions
4 Global Intraveno(IV) Iron Drugs Consumption by Regions
5 Global Intraveno(IV) Iron Drugs Production, Revenue, Price Trend by Type
6 Global Intraveno(IV) Iron Drugs Market Analysis by Applications
7 Company Profiles and Key Figures in Intraveno(IV) Iron Drugs Business
8 Intraveno(IV) Iron Drugs Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Intraveno(IV) Iron Drugs Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source